These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 23983424)
1. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled. Greene CM; Varley RB; Lawless MW World J Gastroenterol; 2013 Aug; 19(32):5212-26. PubMed ID: 23983424 [TBL] [Abstract][Full Text] [Related]
2. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Gailhouste L; Ochiya T Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. Lamontagne J; Steel LF; Bouchard MJ World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985 [TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. Hou W; Bonkovsky HL World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777 [TBL] [Abstract][Full Text] [Related]
5. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640 [TBL] [Abstract][Full Text] [Related]
7. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707 [TBL] [Abstract][Full Text] [Related]
8. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Oura K; Morishita A; Masaki T Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811 [TBL] [Abstract][Full Text] [Related]
9. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival. Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373 [TBL] [Abstract][Full Text] [Related]
10. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Chu R; Mo G; Duan Z; Huang M; Chang J; Li X; Liu P Cell Commun Signal; 2014 Jul; 12():45. PubMed ID: 25012758 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
13. Epigenetics of hepatocellular carcinoma: role of microRNA. Khare S; Zhang Q; Ibdah JA World J Gastroenterol; 2013 Sep; 19(33):5439-45. PubMed ID: 24023486 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis. Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408 [TBL] [Abstract][Full Text] [Related]
16. Iron overload in nonalcoholic steatohepatitis. Fujita N; Takei Y Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026 [TBL] [Abstract][Full Text] [Related]
17. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC. Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Hung CH; Chiu YC; Chen CH; Hu TH Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233 [TBL] [Abstract][Full Text] [Related]
19. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review). Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436 [TBL] [Abstract][Full Text] [Related]
20. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]